SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-150297
Filing Date
2016-10-14
Accepted
2016-10-14 16:16:43
Documents
33
Period of Report
2016-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-19610_110q.htm 10-Q 338526
2 EX-31.1 a16-19610_1ex31d1.htm EX-31.1 10791
3 EX-31.2 a16-19610_1ex31d2.htm EX-31.2 10771
4 EX-32.1 a16-19610_1ex32d1.htm EX-32.1 6260
5 EX-32.2 a16-19610_1ex32d2.htm EX-32.2 6235
  Complete submission text file 0001104659-16-150297.txt   1313244

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20160831.xml EX-101.INS 174842
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20160831.xsd EX-101.SCH 14651
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20160831_cal.xml EX-101.CAL 14929
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20160831_lab.xml EX-101.LAB 135512
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20160831_pre.xml EX-101.PRE 85029
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20160831_def.xml EX-101.DEF 32376
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 161937238
SIC: 2835 In Vitro & In Vivo Diagnostic Substances